PLANTATION, Fla., July 18, 2014 /PRNewswire/ -- Neurotrope, Inc. (OTCQB: NTRP) today announced that on July 16, 2014, its Board of Directors appointed Co-Chairmen Charles S. Ramat and Paul Freiman as Co-Chief Executive Officers on an interim basis, effective immediately. Messrs. Ramat and Freiman replace Dr. James New, who is no longer Chief Executive Officer of Neurotrope Bioscience, Inc., (a wholly-owned subsidiary of the Company) or the Company and whose employment agreement with Neurotrope Bioscience Inc. terminated as of July 16, 2014. The Board has begun a search for a permanent Chief Executive Officer. Dr. New remains a member of the Company's Board of Directors.
"We recognize Jim's contributions to Neurotrope and are thankful for his management leadership over the past year," stated Messrs. Ramat and Freiman. "We wish him the best in his future endeavors."
Mr. Ramat is currently a private investor and has extensive operational and general business experience in several industries including: biotechnology, medical devices, commercial finance, real estate and mobile communications. From December 2009 until December 2013, Mr. Ramat was a principal investor and consultant to Continental Home Loans, the third largest FHA mortgage originator in New York State, with operations in 22 states and with annual originations and servicing portfolio both in excess of $1 billion. Since 2006, he has developed land, principally 1,000 acres of private gated communities, with a strong emphasis on environmentally friendly practices, in upstate New York. From 2002 to 2005, Mr. Ramat was the President and Chief Executive Officer of Kushner Companies, managing 25,000 apartment units and a commercial portfolio exceeding five million square feet.
Mr. Freiman is currently an independent pha
|SOURCE Neurotrope, Inc.|
Copyright©2014 PR Newswire.
All rights reserved